. 2023 Jul 1;57(4):169–175. doi: 10.5152/j.aott.2023.23026
Content of this journal is licensed under a Table 1.
Demographic characteristics of the patients (Pearson chi-square test)
| FITBONE | PRECİCE | P | |||
|---|---|---|---|---|---|
| Gender | Male | 8 (40%) | Male | 12 (57.1%) | |
| Female | 12 (60%) | Female | 9 (42.9%) | .272 | |
| Side | Right | 9 (45%) | Right | 11 (52.4%) | |
| Left | 11 (55%) | Left | 10 (47.6%) | .636 | |
| Etiology | Posttraumatic | 6 (30%) | Posttraumatic | 10 (47.6%) | |
| DHD sequelae | 4 (20%) | DHD sequelae | 2 (9.5%) | ||
| Hemihypertrophy | 4 (20%) | Hemihypertrophy | 2 (9.5%) | ||
| Congenital | 2 (10%) | Congenital | 5 (23.8%) | ||
| Polio sequelae | 2 (10%) | Polio sequelae | 1 (4.8%) | ||
| Fibula hemimelia | 1 (5%) | Achondroplasia | 1 (4.8%) | ||
| Achondroplasia | 1 (5%) | Fibula hemimelia | 0 (0%) | .553 | |
| Nail application | Retrograde femoral nail | 13 (65%) | Retrograde femoral nail | 3 (14.29%) | |
| Antegrade femoral nail | 5 (25%) | Antegrade femoral nail | 12 (57.14%) | ||
| Tibial nail | 2 (10%) | Tibial nail | 6 (28.57%) | .040 | |
| Surgical purpose | Isolated lengthening | 11 (55%) | Isolated lengthening | 16 (76.2%) | |
| Varus correct. + lengt. | 5 (25%) | Varus correct. + lengt. | 3 (14.3%) | ||
| Valgus correct. + lengt. | 4 (20%) | Valgus correct. + lengt. | 2 (9.5%) | .355 | |